| Symbol | ZYME |
|---|---|
| Name | ZYMEWORKS INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Address | 1385 WEST 8TH AVENUE,SUITE 540, VANCOUVER, British Columbia, V6H 3V9, Canada |
| Telephone | +1 604 678-1388 |
| Fax | — |
| — | |
| Website | https://www.zymeworks.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001937653 |
| Description | Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enable precise engineering of differentiated product candidates. Its lead clinical candidate, zanidatamab, is a novel Azymetric HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. The company is also advancing a deep preclinical pipeline in oncology and other therapeutic areas. Additional info from NASDAQ: |
Zymeworks to Report Second Quarter 2026 Financial Results on August 6, 2026
Read moreHollywood Mark 🟢 acquired 939 shares of Zymeworks Inc. (ZYME) at $22.22 Transaction Date: Jul 06, 2026 | Filing ID: 000009
Read moreZymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting ADC ZW191 at ESMO Gynaecological Cancers Congress 2026
Read moreSchneider Paul R 🟢 acquired 297.0K shares (2 derivative) of Zymeworks Inc. (ZYME) at $24.57 ($4.4M) Transaction Date: May 13, 2026 | Filing ID: 227140
Read moreNew Form 3 - Zymeworks Inc. <b>Filed:</b> 2026-05-15 <b>AccNo:</b> 0001193125-26-227111 <b>Size:</b> 15 KB
Read moreNew Form SCHEDULE 13G/A - Zymeworks Inc. <b>Filed:</b> 2026-05-15 <b>AccNo:</b> 0001104659-26-062529 <b>Size:</b> 10 KB
Read more